Sun Pharma

Motilal Oswal latest portfolio update, Motilal Oswal top stocks 2025

Motilal Oswal portfolio shakeup: Autos upgraded, Lupin in, Sun Pharma out, Swiggy joins — What’s driving the change

Motilal Oswal revamps model portfolio, upgrading autos, adding Swiggy and Lupin; discover what’s fueling these strategic moves!

October 6, 2025 11:22 IST

US tariff on Indian pharma: Nomura sees $100 million tariff risk for Sun Pharma

Nomura warns Sun Pharma faces $100 million risk from potential US tariffs on specialty drugs. Explore the impact on Indian…

September 30, 2025 17:54 IST

Nifty Pharma index today, Nifty Pharma down, Indian pharma stocks fall

Pharma stocks crack, Nifty Pharma Index slips over 2% as Trump unveils 100% tariff: 3 key factors investors must watch

Nifty Pharma index drops over 2% after Trump unveils 100% tariff on drug imports – see which stocks are most…

September 26, 2025 11:50 IST

Sun Pharmaceutical share price today, Sun Pharma, Sun Pharma stock, Sun Pharma share price

Sun Pharma in spotlight: Buy or Hold? 2 brokerages, 2 targets – Here’s what it means for investors

Sun Pharma receives a ‘Buy’ from Jefferies and ‘Hold’ from Nuvama; review both targets to decide your next move on…

September 25, 2025 10:50 IST

Markets stable after US Fed rate cut: Nifty closes above 25,400 led by tech and pharma – 5 key highlights

Sensex and Nifty close higher led by gains in pharma and IT stocks; explore today’s top movers and sector performance.

September 18, 2025 15:46 IST

Jefferies buy rating, auto stocks to buy, pharma stocks to buy, steel sector stocks, top brokerage recommendations September 2025

Jefferies’ September shopping list: M&M, Sun Pharma & 3 more stocks set to rally – Do you own them?

Jefferies names M&M, TVS Motor, Jindal Stainless, Sun Pharma, and Mankind Pharma as top September buys—see why these stocks could…

September 15, 2025 11:15 IST

From Vodafone Idea, Bajaj Auto to Godrej Properties – Here are 8 stocks in focus today

Track key stock moves today as companies like Vodafone Idea, Bajaj Auto, and Godrej Properties announce major updates – get…

September 10, 2025 06:33 IST

Nifty recovery, Trump tariff impact, profit booking

Market watchlist: From Vedanta, Adani Enterprise to Sun Pharma, 11 stocks set to see a turnaround

Track Nifty as Trump’s tariff threats shake its recovery, pharma rallies, and metals falter – see how markets may move…

Updated: August 25, 2025 23:27 IST

Markets end the week lower: Nifty closes below 25,000; Nifty Bank down 1% – 4 key highlights

Sensex and Nifty closed in the red; see which stocks gained, lost, and made big moves in today’s volatile session…

August 22, 2025 15:41 IST

Big pharma bet: Jefferies lists out India’s next CRDMO multibaggers with up to 37% upside potential

Growth prescription: The future is specialty; Sun Pharma, Dr Reddy’s, Cipla lead, says Nomura

Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…

August 11, 2025 16:58 IST

FIIs selling August 2025, Adani Enterprises stock trend, JSW Steel outlook

Market Watchlist: Index Futures sink to 1-month lows —11 must-watch stocks including Adani Power, Sun Pharma on FII radar

Discover key stocks FIIs are selling in August and which sectors show further downside – read the full market outlook…

Updated: August 4, 2025 11:49 IST

Markets start August weak; Trump tariff weighs on sentiment, Nifty, Sensex slide over 3% in July – 3 Key highlights

Markets saw mixed moves as Sun Pharma and PNB Housing tumbled, while Trent and renewables surged – see which stocks…

August 1, 2025 15:38 IST

midday stock movers, MRF share price, PN Gadgil Jewellers Q1 results

Stocks making the biggest moves midday: Suzlon, Waaree Energies, PNB Housing Finance and more

Stocks like Suzlon and PNB Housing see major price swings amid market downturn – see which shares are moving today!

August 1, 2025 14:31 IST

Sun Pharma launches LEQSELVI in US for severe hair loss

Sun Pharma launches key alopecia drug in US, experts estimate $200–300 million market potential

Updated: July 15, 2025 14:30 IST

Markets muted amid fresh tariff buzz: Nifty at 25,500, Sensex down 60 points; HCL Tech, Infosys among key losers

Indian stock markets slip amid global tariff threats and key earnings ahead; track levels and updates now.

July 9, 2025 09:21 IST

Nuvoco Vistas share price, Nuvoco stock rating

Market watchlist: Tata Steel, JSW Steel, Cipla among 9 stocks in spotlight; FIIs turn bearish on earnings jitters

Markets remain cautious ahead of earnings; track Tata Steel, JSW Steel, and Cipla for breakout moves this week.

July 7, 2025 05:30 IST

Sun Pharma, pharma industry, Dilip Shanghvi, USFDA, manufacturing, compliance issues, US FDA inspection, R&D spend, revenue, specialty revenue

Is the Halol hurdle too high for Sun Pharma? 4 reasons why Nomura sees limited upside potential

Sun Pharma’s Halol issues limit potential; Nomura sees a 17% upside. Stay updated on regulatory developments at Halol facility.

June 17, 2025 12:34 IST

Sun Pharma, pharma industry, Halol facility, inspection, US FDA, Good Manufacturing Practices, import, leadership change, managing director, appointment

Compliance review: US FDA issues 8 observations for Sun Pharma’s Halol plant following GMP inspection

Sun Pharma said the US FDA issued a Form-483 with eight observations after inspecting its Halol facility from June 2–13.

Updated: June 16, 2025 10:13 IST

Related News

Who is Alexandr Wang? The 28-year-old hired by Mark Zuckerberg for $14 billion to head Meta’s Superintelligence Labs

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Engineer denied B2 visa despite stable job and business, officer says ‘unfortunately you are…’

Employee quits google job, Google Manager Quits Rs 3.4 Crore Job

Google manager quits Rs 3.4 crore job, says ‘the work was pleasant, but…’

Laid off before retirement, called back months later: Woman turns tables on former employer, says ‘that’s not going to…’

India’s outbound FDI moderates to $4.41 billion in September; equity commitments surge

Economy4 hr ago

India’s outward foreign direct investment decreased to $4.41 billion in September, with equity commitments seeing a significant rise. Loan-based FDI and guarantees extended to overseas subsidiaries dropped, while outbound flows jumped from $2.59 billion in August. Major outbound deals in September included investments in Luxembourg, the Netherlands, and the UK.

View all shorts